Oral supplementation with bovine whey-derived Ig-rich fraction and lactoferrin improves SCORAD and DLQI in atopic dermatitis

J Dermatol Sci. 2017 Feb;85(2):143-146. doi: 10.1016/j.jdermsci.2016.11.009. Epub 2016 Dec 13.

Authors

Philip L Tong¹, Nicholas P West², Amanda J Cox², Val J Gebski³, Annabelle M Watts², Annabel Dodds⁴, Barbara Fazekas de St Groth¹, Allan W Cripps⁵, Stephen Shumack⁴

Affiliations

¹ Centenary Institute, Newtown, NSW, Australia; Discipline of Dermatology, Sydney Medical School, University of Sydney, Sydney, Australia.
² Menzies Health Institute QLD and School of Medical Science, Griffith University, QLD 4215, Australia.
³ NHMRC Clinical Trials Centre, University of Sydney, NSW, 1450, Australia.
⁴ Department of Dermatology, Northern Medical School, University of Sydney, Sydney, NSW, Australia.
⁵ Menzies Health Institute QLD and School of Medical Science, Griffith University, QLD 4215, Australia. Electronic address: [email protected].

PMID: 28012820
DOI: 10.1016/j.jdermsci.2016.11.009

No abstract available

Publication types

Clinical Trial, Phase II
Letter
Randomized Controlled Trial

MeSH terms

Administration, Oral
Adult
Animals
Cattle
Dermatitis, Atopic / blood
Dermatitis, Atopic / immunology
Dermatitis, Atopic / therapy*
Double-Blind Method
Female
Humans
Immunoglobulins / administration & dosage
Immunoglobulins / therapeutic use*
Lactoferrin / administration & dosage
Lactoferrin / therapeutic use*
Male
Middle Aged
Quality of Life
Severity of Illness Index
Surveys and Questionnaires
Tablets
Whey Proteins / administration & dosage
Whey Proteins / therapeutic use*
Young Adult

Substances

Immunoglobulins
Tablets
Whey Proteins
Lactoferrin